Cytosorbents Corporation Analysis
| Analyst Ratings |
|
Average Target Price
|
9.00
|
|
Average Rating
|
4.67
|
|
# Strong Buys
|
2
|
|
# Buys
|
1
|
|
# Holds
|
0
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2022-09-30
|
-0.16
|
-0.28
|
-0.12
|
-75.00%
|
|
2022-06-30
|
-0.13
|
-0.25
|
-0.12
|
-92.31%
|
|
2022-03-31
|
-0.12
|
-0.21
|
-0.09
|
-75.00%
|
|
2021-12-31
|
-0.13
|
-0.21
|
-0.08
|
-61.54%
|
|
2021-09-30
|
-0.12
|
-0.15
|
-0.03
|
-25.00%
|
|
2021-06-30
|
-0.04
|
-0.11
|
-0.07
|
-175.00%
|
|
2021-03-31
|
-0.03
|
-0.10
|
-0.07
|
-233.33%
|
|
2020-12-31
|
-0.04
|
-0.01
|
0.03
|
75.00%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
-0.74
|
|
2021-12-31
|
-0.57
|
|
2020-12-31
|
-0.21
|
|
2019-12-31
|
-0.59
|
|
2018-12-31
|
-0.56
|
|
2017-12-31
|
-0.27
|
|
2016-12-31
|
-0.48
|
|
2015-12-31
|
-0.33
|
|
2014-12-31
|
-1.06
|
|
2013-12-31
|
-1.79
|
|
2011-12-31
|
-1.38
|
|
2010-12-31
|
-1.44
|
|
2009-12-31
|
-2.40
|
|
2008-12-31
|
-7.44
|
|
2006-12-31
|
-2.58
|